Literature DB >> 1426154

Dehydroepiandrosterone sulfate-binding sites in plasma membrane from human uterine cervical fibroblasts.

A Imai1, T Ohno, T Tamaya.   

Abstract

Dehydroepiandrosterone sulfate (DHA-S) plays a critical role in cervical dilatation at labor. Incubation of cervical fibroblasts with [3H]DHA-S caused a rapid and saturable increase in cellular radioactivity: an apparent equilibrium was reached by 2 min. There was no detectable conversion of DHA-S into DHA or oestradiol. When the fibroblasts loaded with [3H]DHA-S were homogenized and fractionated, the specific radioactivity in the plasma membrane fraction was enriched approximately 8- to 9-fold compared with the whole homogenate; only low amounts of radioactivity were observed in the other subcellular fractions. The binding of DHA-S to plasma membrane preparations showed saturation kinetics with an apparent equilibrium dissociation constant (Kd) of 12 nM, and the binding capacity (Bmax) was calculated to be 1.25 fmol/mg protein. Neither DHA nor oestrone sulfate affected [3H]DHA-S binding to the plasma membrane. The plasma membranes of skin fibroblasts did not show specific binding sites for DHA-S. These findings demonstrate the presence of specific binding sites for DHA-S in the plasma membrane of cervical stroma cells. The fetal adrenal steroid may exert its action on cervical ripening at least in part through membrane-associated binding sites, or receptors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1426154     DOI: 10.1007/bf01919152

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  17 in total

1.  ENDOCRINE FUNCTIONS OF THE HUMAN FETOPLACENTAL UNIT.

Authors:  E DICZFALUSY
Journal:  Fed Proc       Date:  1964 Jul-Aug

2.  Relationship between dilatation of the rat uterine cervix and a small dermatan sulfate proteoglycan.

Authors:  R Kokenyesi; J F Woessner
Journal:  Biol Reprod       Date:  1990-01       Impact factor: 4.285

3.  Hormones and cervical ripening: dehydroepiandrosterone sulfate, estradiol, estriol, and progesterone.

Authors:  L J Zuidema; F Khan-Dawood; M Y Dawood; B A Work
Journal:  Am J Obstet Gynecol       Date:  1986-12       Impact factor: 8.661

4.  The effect of pregnancy and labor on the human cervix: changes in collagen, glycoproteins, and glycosaminoglycans.

Authors:  D N Danforth; A Veis; M Breen; H G Weinstein; J C Buckingham; P Manalo
Journal:  Am J Obstet Gynecol       Date:  1974-11-01       Impact factor: 8.661

5.  Study of the metabolic clearance rate of dehydroisoandrosterone sulfate in pregnancy.

Authors:  N F Gant; H T Hutchinson; P K Siiteri; P C MacDonald
Journal:  Am J Obstet Gynecol       Date:  1971-10-15       Impact factor: 8.661

Review 6.  Recent insights in phosphatidylinositol signaling.

Authors:  P W Majerus; T S Ross; T W Cunningham; K K Caldwell; A B Jefferson; V S Bansal
Journal:  Cell       Date:  1990-11-02       Impact factor: 41.582

7.  Specific binding sites for oestrogen at the outer surfaces of isolated endometrial cells.

Authors:  R J Pietras; C M Szego
Journal:  Nature       Date:  1977-01-06       Impact factor: 49.962

8.  Collagen changes in the human uterine cervix at parturition.

Authors:  H P Kleissl; M van der Rest; F Naftolin; F H Glorieux; A de Leon
Journal:  Am J Obstet Gynecol       Date:  1978-04-01       Impact factor: 8.661

9.  Elevated tissue levels of collagenase during dilation of uterine cervix in human parturition.

Authors:  M R Rajabi; D D Dean; S N Beydoun; J F Woessner
Journal:  Am J Obstet Gynecol       Date:  1988-10       Impact factor: 8.661

10.  Ripening of the human uterine cervix related to changes in collagen, glycosaminoglycans, and collagenolytic activity.

Authors:  N Uldbjerg; G Ekman; A Malmström; K Olsson; U Ulmsten
Journal:  Am J Obstet Gynecol       Date:  1983-11-15       Impact factor: 8.661

View more
  1 in total

Review 1.  Anti-glucocorticoid effects of dehydroepiandrosterone (DHEA).

Authors:  M Kalimi; Y Shafagoj; R Loria; D Padgett; W Regelson
Journal:  Mol Cell Biochem       Date:  1994-02-23       Impact factor: 3.396

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.